Ulwazi Lomkhiqizo
I-Dipeptide diaminobutyroyl benzylamide diacetate ithathwa njenge-neurotransmitter-inhibiting peptide, okusho ukuthi ingaba nekhono lokukhomba imigqa yokukhuluma.
I-SYN-AKE isebenza njengomkhiqizo osebenzayo wokulwa nemibimbi ikakhulukazi ngokuphumuza imisipha yobuso. I-SYN-AKE isebenza kulwelwesi lwe-postsynaptic futhi iphikisana ne-muscle nicotinic acetylcholine receptors. I-SYN-AKE ibophezela kuma-subunits we-nicotinic acetylcholine receptors, ngaleyo ndlela ivimbele ukubophezela kwe-acetylcholine kumamukeli, okuholela ekuvinjweni kwe-receptor okuqhubekayo. Esimweni esivaliwe, i-sodium ion ayikwazi ukudliwa, ayikwazi ukuchithwa, futhi ukudluliswa kwe-nerve excitation kuvinjiwe, ngakho-ke imisipha emisebeni ikhululekile, ngaleyo ndlela inciphisa imibimbi, futhi ngesikhathi esifanayo ikhulisa umswakama nokudla kwesikhumba ukuze kuvikelwe. isikhumba ngendlela eyindilinga.
Umsebenzi
I-anti wrinkle kanye ne-anti-aging, ithuthukisa ikhwalithi yesikhumba, ubuso, intamo kanye nemikhiqizo yokunakekelwa kwezandla. Ingangezwa emikhiqizweni yobuhle nesikhumba, njenge-lotion, imaski yobuso, ukhilimu wasekuseni nakusihlwa, i-essence yamehlo, njll.
ISItifiketi SOKUHLAZIYA
Igama Lomkhiqizo | I-Benzylamide I-Diacetate I-Dipeptide I-Diaminobutyroyl | Ukucaciswa | Inkampani Standard |
Cas No. | 823202-99-9 | Usuku Lokukhiqiza | 2023.11.22 |
Ubuningi | 100KG | Idethi yokuhlaziya | 2023.11.28 |
Inombolo yeqoqo. | I-BF-231122 | Usuku Eliphelela ngalo | 2025.11.21 |
Izinto | Imininingwane | Imiphumela | |
Isivivinyo | ≥95% | 97.2% | |
Ukubukeka | Impushana emhlophe | Kuyavumelana | |
Ukuhlonza | 375.23±1 | 376.2(M+1) | |
Ukungcola | ≤5% | 2.8% | |
Okuqukethwe kwe-Peptide | ≥80% | 81.3% | |
I-acetate | ≤15% | 12.1% | |
PH | 3.0-6.0 | 5.35 | |
Amanzi | ≤8% | 3.8% | |
Ukuncibilika | ≥100mg/ml(H2O) | Kuyavumelana | |
Isiphetho | Lesi sampula sihlangabezana nezicaciso. |